Insider reports 72,000-share 10b5-1 sales

Reported dispositions by Christopher Brian Slowe under a Rule 10b5-1 plan.

Rhea-AI Filing Summary

Reported dispositions by Christopher Brian Slowe under a Rule 10b5-1 plan. The filing lists six open-market sales of Common stock on between and , totaling 72,000 shares for aggregate proceeds shown as $10,699,160.15 across those trades. The excerpt also lists 59,500 Restricted Stock Units granted on .

Insights

Corporate Governance Analyst

Multiple scheduled 10b5-1 sales by an insider, routine liquidity events.

The excerpt shows six separate 10b5-1 sales by Christopher Brian Slowe with share counts and gross proceeds recorded per trade. The transactions are presented as sales executed under a pre-arranged plan rather than discretionary open-market trades.

Timing and exact plan parameters are not provided in the excerpt; subsequent filings may show plan start dates or additional transactions.

Key Figures

Restricted Stock Units: 59,500 shares Sale on 05/22/2026: 12,000 shares Sale on 05/08/2026: 14,000 shares +5 more

8 metrics

Restricted Stock Units 59,500 shares grant dated 03/21/2024

Sale on 05/22/2026 12,000 shares proceeds $1,709,996.40

Sale on 05/08/2026 14,000 shares proceeds $2,200,727.85

Sale on 04/22/2026 11,500 shares proceeds $1,865,158.30

Sale on 04/08/2026 15,500 shares proceeds $2,335,411.50

Sale on 03/23/2026 9,500 shares proceeds $1,342,137.60

Sale on 03/09/2026 9,500 shares proceeds $1,297,229.50

Total reported sales (sum of rows) 72,000 shares aggregate of six 10b5-1 trades listed in the excerpt

Key Terms

10b5-1, Restricted Stock Units, Form 144

3 terms

10b5-1 regulatory

"10b5-1 Sales for CHRISTOPHER BRIAN SLOWE"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Restricted Stock Units financial

"Restricted Stock Units | Issuer | 59500 | 03/21/2024"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transactions does the RDDT Form 144 report show for Christopher Brian Slowe?

The filing shows six 10b5-1 sales totaling 72,000 shares. Each trade lists date, shares sold, and gross proceeds, with individual sale proceeds shown in the excerpt.

How many Restricted Stock Units are listed in the excerpt for RDDT?

The excerpt lists 59,500 Restricted Stock Units dated 03/21/2024. That grant is shown separately from the listed sales and appears as awarded securities in the filing.

What dates and per-trade proceeds are disclosed for the sales in the excerpt?

Sales shown include 05/22/2026 (12,000, $1,709,996.40), 05/08/2026 (14,000, $2,200,727.85), 04/22/2026 (11,500, $1,865,158.30), 04/08/2026 (15,500, $2,335,411.50), 03/23/2026 (9,500, $1,342,137.60), and 03/09/2026 (9,500, $1,297,229.50) as shown in the excerpt.

Were the sales described in the filing made under a trading plan?

Yes. Each disposition in the excerpt is labeled as a 10b5-1 sale, indicating execution under a pre-arranged trading plan as stated in the filing text provided.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/27/2026 - 04:32 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001924253
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	REDDIT INC
SEC File Number	001-41983
Address of Issuer	303 2nd Street, South Tower, 5th Floor San Francisco CALIFORNIA 94107
Phone	4154948016
Name of Person for Whose Account the Securities are To Be Sold	CHRISTOPHER BRIAN SLOWE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	59500	8606080.00	141965642	05/27/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/21/2024	Restricted Stock Units	Issuer			59500	03/21/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CHRISTOPHER BRIAN SLOWE 303 2nd Street, South Tower, 5th Floor San Francisco CA 94107	Common	05/22/2026	12000	1709996.40
10b5-1 Sales for CHRISTOPHER BRIAN SLOWE 303 2nd Street, South Tower, 5th Floor San Francisco CA 94107	Common	05/08/2026	14000	2200727.85
10b5-1 Sales for CHRISTOPHER BRIAN SLOWE 303 2nd Street, South Tower, 5th Floor San Francisco CA 94107	Common	04/22/2026	11500	1865158.30
10b5-1 Sales for CHRISTOPHER BRIAN SLOWE 303 2nd Street, South Tower, 5th Floor San Francisco CA 94107	Common	04/08/2026	15500	2335411.50
10b5-1 Sales for CHRISTOPHER BRIAN SLOWE 303 2nd Street, South Tower, 5th Floor San Francisco CA 94107	Common	03/23/2026	9500	1342137.60
10b5-1 Sales for CHRISTOPHER BRIAN SLOWE 303 2nd Street, South Tower, 5th Floor San Francisco CA 94107	Common	03/09/2026	9500	1297229.50

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 03/21/2024 through 02/20/2025.
Date of Notice	05/27/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Christopher Brian Slowe
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)